Get the free Investigational New Drug Application Form FDA 1571

Get Form

We are not affiliated with any brand or entity on this form

Fill out

Complete the form online in a simple drag-and-drop editor.

eSign

Add your legally binding signature or send the form for signing.

Share

Share the form via a link, letting anyone fill it out from any device.

Export

Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

Learn more about security

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.

What is IND Application Form

The Investigational New Drug Application Form FDA 1571 is a government document used by sponsors to submit an IND application to the FDA for clinical investigations.

pdfFiller scores top ratings on review platforms

Show more Show less

Fill fillable IND Application form: Try Risk Free

Rate free IND Application form

4.4

satisfied

28 votes

Who needs IND Application Form?

Explore how professionals across industries use pdfFiller.

IND Application Form is needed by:

Clinical trial sponsors seeking FDA approval
Pharmaceutical companies conducting drug trials
Research institutions launching clinical investigations
Authorized representatives of drug sponsors
Regulatory affairs professionals
Investigator sites involved in clinical trials

Comprehensive Guide to IND Application Form

Understanding the Investigational New Drug Application Form FDA 1571

The Investigational New Drug Application Form FDA 1571 serves a crucial role in the drug application process. This form is defined as the primary document that sponsors of clinical investigations must complete to submit their IND application. It is essential during the initial stages of drug development, ensuring that all necessary information about the investigational drug and its usage is provided.

The FDA Form 1571 is utilized by various clinical trial sponsors, including pharmaceutical companies and research institutions. Its importance cannot be overstated, as it lays the foundation for regulatory compliance and future evaluations of drug safety.

Purpose and Benefits of the Investigational New Drug Application Form FDA 1571

The primary purpose of the Investigational New Drug Application Form FDA 1571 is to ensure that drug sponsors comply with FDA regulations. This compliance enables effective communication between sponsors and the FDA, significantly impacting the clinical investigation process.

By using the IND submission form, sponsors can expedite the review of their drug trial applications. The benefits also extend to safety and efficacy assessments, which are paramount for obtaining FDA approval and advancing to clinical trials.

Key Features of the Investigational New Drug Application Form FDA 1571

This form encompasses several key features that facilitate its completion. It includes fillable fields that require essential information, such as sponsor details and specifications about the investigational drug. Detailed sections are dedicated to safety data and clinical trial protocols to ensure a comprehensive submission.

Clear instructions for accurate completion to avoid common mistakes
Multiple sections for relevant contact information
Designated spaces for safety and efficacy assessments

Who Needs the Investigational New Drug Application Form FDA 1571?

The primary audience for the Investigational New Drug Application Form FDA 1571 includes sponsors and their authorized representatives. Understanding the definition and role of the sponsor is crucial, as they are responsible for completing the application and ensuring all required information is correctly provided.

Authorized representatives must sign the form, which adds another layer of accountability. This requirement is particularly important for pharmaceutical companies and research institutions, emphasizing the need for professional diligence throughout the process.

Filing Requirements and Important Deadlines

Submitting the Investigational New Drug Application Form FDA 1571 requires adherence to specific filing requirements and deadlines. Timelines for submission should be clearly understood to ensure compliance and prevent penalties for late submissions.

Detailed timeline for filing the IND application
Consequences of submitting late
List of required supplementary documents and materials

How to Fill Out the Investigational New Drug Application Form FDA 1571 Online (Step-by-Step)

Completing the Investigational New Drug Application Form FDA 1571 can be done efficiently online. Here’s a step-by-step guide to help you fill out the form using pdfFiller:

Access the form on pdfFiller.
Begin by entering the “Name of Sponsor” and the “Date of Submission.”
Focus on key fields, especially the "Signature" line for the sponsor or their authorized representative.
Review all entries to ensure accuracy and completeness.
Submit the form once everything is correctly filled out.

How to Submit the Investigational New Drug Application Form FDA 1571 and Track Your Submission

After completing the Investigational New Drug Application Form FDA 1571, the submission process can follow two methods: online or by mail. Each method has its own advantages, and it's essential to choose the one that fits your needs best.

Confirming the submission status is crucial for sponsors. Tracking the submission enables them to monitor processing times effectively and take necessary follow-up actions if required.

Using pdfFiller for Your Investigational New Drug Application Form FDA 1571 Needs

Utilizing pdfFiller can significantly streamline the process of managing the Investigational New Drug Application Form FDA 1571. This platform offers a range of benefits, including the ability to edit, fill, and eSign the form seamlessly.

Key features of pdfFiller include robust security protocols, such as 256-bit encryption, which ensures the protection of sensitive information during form completion. Its user-friendly interface caters to both beginners and experienced users alike, making it an ideal choice for sponsors.

Additional Resources and Support for the Investigational New Drug Application Process

Access to additional resources and support is vital for navigating the IND application process. Sponsors can find direct links to FDA resources, which provide detailed information related to IND applications.

Potential contacts for legal advice and expert consultation
Community forums for sharing experiences among sponsors

Experience Seamless Completion of Your Investigational New Drug Application Form FDA 1571 with pdfFiller

Choosing pdfFiller for completing your Investigational New Drug Application Form FDA 1571 ensures a seamless experience. The platform provides efficient tools that allow for secure document management, enabling sponsors to focus on the essential aspects of their applications.

With its advantages clearly outlined, sponsors are encouraged to engage with pdfFiller for all their form completion needs, ensuring they navigate the application process smoothly.

Last updated on Apr 30, 2026

How to fill out the IND Application Form

1.

To begin, access pdfFiller and log into your account or create a new one if necessary.
2.

Use the search bar to find the Investigational New Drug Application Form FDA 1571 by typing the form name.
3.

Once located, click on the form to open it within the pdfFiller interface, which allows for easy editing.
4.

Familiarize yourself with the navigation panel, where you can zoom in/out and move through the pages of the form.
5.

Before filling out the form, gather all necessary information, including sponsor details, drug information, clinical trial protocols, and safety data.
6.

Begin filling in the blank fields, ensuring all required sections such as contact information, investigation plan, and drug details are completed.
7.

Utilize checkboxes where appropriate, following the instructions provided in the form template.
8.

After filling out the form, review all entries for accuracy and completeness to prevent errors.
9.

Once satisfied, proceed to finalize the document by selecting the appropriate save option.
10.

You may then download the completed form, or submit it directly through pdfFiller, depending on your submission requirements.

FAQs

If you can't find what you're looking for, please contact us anytime!

Contact Support

Who is eligible to submit the FDA 1571 form?

The FDA 1571 form is intended for sponsors or their authorized representatives who are initiating clinical trials in the U.S. Eligibility includes pharmaceutical companies, research organizations, and academic institutions involved in drug development.

What is the deadline for submitting the FDA 1571 form?

There is no strict deadline for submitting the FDA 1571 form; however, it must be submitted before beginning any clinical trials. Early submission is recommended to allow for potential FDA feedback and modifications.

How do I submit the FDA 1571 form?

You can submit the completed FDA 1571 form either electronically or by mail to the FDA. Electronic submissions are generally preferred, and detailed instructions can be found on the FDA’s website for proper procedures.

What supporting documents are required with the FDA 1571 form?

Accompanying documents may include an Investigator’s Brochure, safety data, clinical trial protocols, and other pertinent information as required by the FDA. Ensure all necessary documents are prepared in advance.

What common mistakes should I avoid when completing the FDA 1571 form?

Common mistakes include incomplete fields, inaccurate contact information, and failing to sign the form. Double-check all sections and ensure you follow the provided instructions carefully.

How long does it take to process the FDA 1571 submission?

Processing times for the FDA 1571 form can vary significantly, but typically it takes 30 days for the FDA to acknowledge receipt and evaluate the submission. Delays can occur if additional information is needed.

Are there any fees associated with submitting the FDA 1571 form?

There are generally no fees associated with submitting the FDA 1571 form, but applicants should check for any potential costs related to additional document submissions or FDA consultations.